CABG

MINNEAPOLIS, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the publication of key clinical data supporting the…

-- Preclinical model data expected to support development of small diameter HAV to treat patients with coronary artery disease-- -- Small-diameter HAV observed to maintain patency and exhibit host-cell remodeling at six months…

Early coronary bypass graft (CABG) -- less than 5 days after ticagrelor (Brilinta) cessation -- proved noninferior to waiting up to 7 days after stopping the antiplatelet in…

Temporary spinal stimulation after coronary artery bypass graft (CABG) surgery for patients with a history of paroxysmal atrial fibrillation (Afib, AF) reduced postoperative…